ArticleAdvances in therapy2026

Revolutionizing 2L+ Myeloma: A Podcast on the New Era of BCMA-Targeted Bispecific Antibody Therapies.

Roberto Mina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.